BioPorto Diagnostics has successfully developed The NGAL Test for the diagnosis of acute kidney injury.
The NGAL test is designed for routine diagnostic use on a wide range of automated clinical chemistry analyzers that are already running in laboratories and hospitals all over the world.
Like the majority of other high volume routine biomarkers the new NGAL test from BioPorto is based on the principle of turbidimetry, recognized to combine high diagnostic performance with fast turnaround time and therefore implicitly addressing the acute aspect of NGAL evaluation.
For more information and technical data, please click here
Pig NGAL ELISA Kit (KIT 044)
Early kidney injury detection has been long sought and NGAL has recently been shown to be the biomarker that could fill this diagnostic gap. Measured from baseline, NGAL levels rise significantly in both urine and blood as a response to kidney injury – nephrotoxic, ischemic or otherwise. The pig is an often used experimental model for medical research because of its close resemblance to humans. Pigs are being used in everything from experimental treatments to experimental surgical procedures.
The pharmaceutical industry is also looking more and more to pigs as a model for drug safety assessment in drug development as pigs are claimed to be more robust than the traditional dog models and in some cases a better mirror model of humans than dogs or even monkeys. Pigs are most often being used for pharmaceutical toxicology in Europe but number of pig experiments on the Americanand other markets are rising rapidly.
Click here to go to the NGAL (pig, neutrophil gelatinase-associated lipocalin) product page
NGAL Rapid ELISA Kit (KIT 037)
NGAL (neutrophil gelatinase associated lipocalin) is a new early marker for acute kidney injury.
NGAL levels rise rapidly after renal injury and have been used in a variety of clinical situations including intensive care, emergency medicine, renal transplantation and procedures involving the use of i.v. contrast media and other nephrotoxic agents.
Our CE-IVD-marked NGAL Rapid ELISA Kit measures human NGAL in urine, plasma or serum.
The positive predictive value for acute renal failure is over 90%.
An ELISA for the determination of human NGAL in urine, plasma or serum as a marker of acute renal injury which may lead to acute renal failure.
